Potentiation of NETs release is novel characteristic of TREM-1 activation and the pharmacological inhibition of TREM-1 could prevent from the deleterious consequences of NETs release in sepsis
Amir Boufenzer(Centre Hospitalier Régional et Universitaire de Nancy), Sébastien Gibot(Centre Hospitalier Régional et Universitaire de Nancy)
Cited by 89
Related Papers
Hydrocortisone in Severe Community-Acquired Pneumonia
|New England Journal of Medicine|2023|438
A Soluble Form of the Triggering Receptor Expressed on Myeloid Cells-1 Modulates the Inflammatory Response in Murine Sepsis
|The Journal of Experimental Medicine|2004|364
Circulating Immature Granulocytes With T-Cell Killing Functions Predict Sepsis Deterioration*
|Critical Care Medicine|2014|109
Prospective evaluation of the efficacy, safety, and optimal biomarker enrichment strategy for nangibotide, a TREM-1 inhibitor, in patients with septic shock (ASTONISH): a double-blind, randomised, controlled, phase 2b trial
|The Lancet Respiratory Medicine|2023|76
sTREM-1 is a specific biomarker of TREM-1 pathway activation
|Cellular and Molecular Immunology|2021|75